Preview Mode Links will not work in preview mode

COVID-19 Evidence presented by InpharmD™

Mar 17, 2021

A randomized multicenter, double-blind, parallel-group, placebo-controlled trial, conducted to investigate the effect of vitamin D3 administration on hospital length of stay and other relevant clinical outcomes and adverse events in hospitalized patients with moderate to severe COVID-19.